San Francisco Otolaryngology selects 2bPrecise platform as foundation for strategy

San Francisco Otolaryngology selected 2bPrecise, a precision medicine data delivery platform, as its foundation for precision medicine strategy, according to a Nov. 11 press release.

The practice will start its focus with pharmacogenomics and may expand to additional genetic testing, the release said. A pilot pharmacogenomics program is underway, and access to all patients is expected for the next year.

"Our interest in precision medicine focuses on general patient wellness," Jacob Johnson, MD, president of San Francisco Otolaryngology, said in the release. "We find the drugs patients take have an important effect on the main variables we assess: whether they are able to exercise, are cognitively intact, engage in social interaction and are safe from falling."

Read the full release here.

More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance


© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers